A Proposed Ethical Framework for Prescription Drug Benefit Allocation Policy

J. Russell Teagarden MA (vice president), Norman Daniels PhD (professor), James E. Sabin MD (Professor)
{"title":"A Proposed Ethical Framework for Prescription Drug Benefit Allocation Policy","authors":"J. Russell Teagarden MA (vice president),&nbsp;Norman Daniels PhD (professor),&nbsp;James E. Sabin MD (Professor)","doi":"10.1331/10865800360467079","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives:</h3><p>To present an ethical framework that could aid prescription drug benefit design and to propose that such a framework could be organized around a benefit allocation hierarchy.</p></div><div><h3>Summary:</h3><p>Four hierarchical levels of allocation are proposed, as follows: (1) drug categories and subcategories, (2) individual drugs within covered drug categories, (3) specific indications of covered drugs, and (4) special features of drug use, such as quantities covered for specific indications. Rationales for decision making should address the distinct ethical issues apparent at each level.</p></div><div><h3>Conclusion:</h3><p>Ethical issues associated with designing and managing a pharmacy benefit can be identified by using a hierarchical prescription drug allocation scheme. Articulating these issues is an important first step toward arriving at a fully developed framework that will serve to produce rationales acceptable to typical stakeholders in prescription drug benefits.</p></div>","PeriodicalId":79444,"journal":{"name":"Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)","volume":"43 1","pages":"Pages 69-74"},"PeriodicalIF":0.0000,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1331/10865800360467079","citationCount":"11","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1086580215300784","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 11

Abstract

Objectives:

To present an ethical framework that could aid prescription drug benefit design and to propose that such a framework could be organized around a benefit allocation hierarchy.

Summary:

Four hierarchical levels of allocation are proposed, as follows: (1) drug categories and subcategories, (2) individual drugs within covered drug categories, (3) specific indications of covered drugs, and (4) special features of drug use, such as quantities covered for specific indications. Rationales for decision making should address the distinct ethical issues apparent at each level.

Conclusion:

Ethical issues associated with designing and managing a pharmacy benefit can be identified by using a hierarchical prescription drug allocation scheme. Articulating these issues is an important first step toward arriving at a fully developed framework that will serve to produce rationales acceptable to typical stakeholders in prescription drug benefits.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
处方药福利分配政策的伦理框架建议
目的:提出一个可以帮助处方药福利设计的伦理框架,并提出这样一个框架可以围绕福利分配层次进行组织。摘要:提出了四个层次的分配:(1)药物类别和子类别,(2)涵盖药物类别中的单个药物,(3)涵盖药物的特定适应症,(4)药物使用的特殊特征,如特定适应症所涵盖的数量。决策的基本原理应该处理在每个层次上明显的不同伦理问题。结论:与药房福利设计和管理相关的伦理问题可以通过使用分层处方药分配方案来识别。阐明这些问题是朝着达成一个充分发展的框架迈出的重要的第一步,该框架将有助于为处方药福利的典型利益相关者提供可接受的理由。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Proving That Pharmaceutical Care Makes a Difference in Community Pharmacy Sesquicentennial Stepping Stone Summits - Summit One: The Best Use of Technology in Pharmacy Practice The Asheville Project: Short-Term Outcomes of a Community Pharmacy Diabetes Care Program The Asheville Project: Factors Associated With Outcomes of a Community Pharmacy Diabetes Care Program The Asheville Project: Long-Term Clinical and Economic Outcomes of a Community Pharmacy Diabetes Care Program
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1